<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-659E62ZM</identifier><date>2016</date><creator>Čemažar, Maja</creator><creator>Dolinšek, Tanja</creator><creator>Potočnik, Tjaša</creator><creator>Prosen, Lara</creator><creator>Serša, Gregor</creator><relation>documents/doc/6/URN_NBN_SI_doc-659E62ZM_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-659E62ZM_001.txt</relation><format format_type="issue">3</format><format format_type="volume">50</format><format format_type="type">article</format><format format_type="extent">str. 274-279, III</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">2416507</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-659E62ZM</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">BRAF inhibitors</subject><subject language_type_id="eng">electrochemotherapy</subject><subject language_type_id="slv">elektrokemoterapija</subject><subject language_type_id="eng">melanom</subject><subject language_type_id="eng">melanoma</subject><subject language_type_id="slv">vemurafenib</subject><subject language_type_id="slv">zaviralci BRAF</subject><title>Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors</title></Record>